Various treatments that improve the symptoms of psoriasis, including epigallocatechin-3-gallate (EGCG), IL-12/23 and TNF-α inhibitors, could also suppress the expression or activity of NF-κB [9]. The gene discussed is NFKB1; the disease is psoriasis.